Literature DB >> 10074489

Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria.

A K Foreman-Wykert1, Y Weinrauch, P Elsbach, J Weiss.   

Abstract

We have shown previously that a group IIA phospholipase A2 (PLA2) is responsible for the potent bactericidal activity of inflammatory fluids against many Gram-positive bacteria. To exert its antibacterial activity, this PLA2 must first bind and traverse the bacterial cell wall to produce the extensive degradation of membrane phospholipids (PL) required for bacterial killing. In this study, we have examined the properties of the cell-wall that may determine the potency of group IIA PLA2 action. Inhibition of bacterial growth by nutrient deprivation or a bacteriostatic antibiotic reversibly increased bacterial resistance to PLA2-triggered PL degradation and killing. Conversely, pretreatment of Staphylococcus aureus or Enterococcus faecium with subinhibitory doses of beta-lactam antibiotics increased the rate and extent of PL degradation and/or bacterial killing after addition of PLA2. Isogenic wild-type (lyt+) and autolysis-deficient (lyt-) strains of S. aureus were equally sensitive to the phospholipolytic action of PLA2, but killing and lysis was much greater in the lyt+ strain. Thus, changes in cell-wall cross-linking and/or autolytic activity can modulate PLA2 action either by affecting enzyme access to membrane PL or by the coupling of massive PL degradation to autolysin-dependent killing and bacterial lysis or both. Taken together, these findings suggest that the bacterial envelope sites engaged in cell growth may represent preferential sites for the action and cytotoxic consequences of group IIA PLA2 attack against Gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074489      PMCID: PMC408128          DOI: 10.1172/JCI5468

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

Review 1.  Antibiotic proteins of polymorphonuclear leukocytes.

Authors:  O Levy
Journal:  Eur J Haematol       Date:  1996-05       Impact factor: 2.997

2.  Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus.

Authors:  R Novick
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

3.  Turnover of bacterial cell wall peptidoglycans.

Authors:  D Boothby; L Daneo-Moore; M L Higgins; J Coyette; G D Shockman
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

4.  Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate.

Authors:  S Forst; J Weiss; P Elsbach; J M Maraganore; I Reardon; R L Heinrikson
Journal:  Biochemistry       Date:  1986-12-30       Impact factor: 3.162

5.  Effect of lipoteichoic acid and lipids on lysis of intact cells of Streptococcus faecalis.

Authors:  R F Cleveland; L Daneo-Moore; A J Wicken; G D Shockman
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

6.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.

Authors:  E Tuomanen; R Cozens; W Tosch; O Zak; A Tomasz
Journal:  J Gen Microbiol       Date:  1986-05

7.  Inhibition of wall autolysis in Streptococcus faecalis by lipoteichoic acid and lipids.

Authors:  R F Cleveland; A J Wicken; L Daneo-Moore; G D Shockman
Journal:  J Bacteriol       Date:  1976-04       Impact factor: 3.490

8.  Regulation of bacterial cell walls: correlation between autolytic activity and cell wall turnover in Staphylococcus aureus.

Authors:  W Wong; A N Chatterjee; F E Young
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

9.  Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes.

Authors:  M W Qoronfleh; B J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

10.  Metabolism of phosphatidylglycerol, lysylphosphatidylglycerol, and cardiolipin of Staphylococcus aureus.

Authors:  S A Short; D C White
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

View more
  23 in total

1.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert Liddington
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 3.  Genetics of kidney failure and the evolving story of APOL1.

Authors:  David J Friedman; Martin R Pollak
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 4.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 5.  Bacterial resistance mechanisms against host defense peptides.

Authors:  Tomaz Koprivnjak; Andreas Peschel
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 6.  How bacterial cell division might cheat turgor pressure - a unified mechanism of septal division in Gram-positive and Gram-negative bacteria.

Authors:  Harold P Erickson
Journal:  Bioessays       Date:  2017-07-12       Impact factor: 4.345

7.  Characterization of Staphylococcus aureus cardiolipin synthases 1 and 2 and their contribution to accumulation of cardiolipin in stationary phase and within phagocytes.

Authors:  T Koprivnjak; D Zhang; C M Ernst; A Peschel; W M Nauseef; J P Weiss
Journal:  J Bacteriol       Date:  2011-06-10       Impact factor: 3.490

8.  IL-25 improves luminal innate immunity and barrier function during parenteral nutrition.

Authors:  Aaron F Heneghan; Joseph F Pierre; Ankush Gosain; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

9.  Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung's disease.

Authors:  Joseph F Pierre; Amanda J Barlow-Anacker; Christopher S Erickson; Aaron F Heneghan; Glen E Leverson; Scot E Dowd; Miles L Epstein; Kenneth A Kudsk; Ankush Gosain
Journal:  J Pediatr Surg       Date:  2014-08       Impact factor: 2.545

10.  Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.

Authors:  Tomaz Koprivnjak; Christopher Weidenmaier; Andreas Peschel; Jerrold P Weiss
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.